Sign In

​​​​​​

Projects

​

Studies Actively Recruiting Participants at HSN Sites

CTN Num​ber​​ Protocol Lead Investigators
CTN-0131

Office-Based Methadone versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment – A Randomized Pragmatic Hybrid Effectiveness/Implementation Trial

 

  • This study is currently recruiting participants with opioid use disorder: ClinicalTrial.Gov study record contacts and locations. 
  • For questions about participating in this study at the Kaiser Permanente Colorado location, please email EMBOSS@kp.org or call 303-739-3666 for information​.

David Fiellin and Paul Joudrey (Co-Lead Investigators)

 

Site PI: Ingrid Binswanger, Kaiser Permanente Colorado

 

 

Studies Led by Health Systems Node (HSN) Investigators

CTN Number​ Protocol Lead Investigators
CTN-0141Health Insurance Instability and Mortality among Patients Receiving Buprenorphine Treatment for Opioid Use Disorder: Linkage of the Prescription Opioid Registry with the National Death IndexAnh Nguyen, Ingrid Binswanger, and Jason Glanz
CTN-0140Cannabis Use in Pregnancy: Psychiatric and Substance Use DisordersKelly Young-Wolff
CTN-0117The Impact of COVID-19 Pandemic on Substance Use Treatment ServicesCynthia Campbell
CTN-0113Validating a DSM-5 Substance Use Symptom Checklist in EHR Data from a Large Primary Care Sample to Support Future Pragmatic Trials and Chronic Care Management of SUDs in Primary Care Emily Williams and Katharine Bradley
CTN 0084-A-2Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder (D-TECT)Cynthia Campbell and Lisa Marsch
CTN-0084-A-1Determining the Optimal Duration of Buprenorphine Treatment to Reduce Relapse, Overdose, and MortalityJason Glanz, Ingrid Binswanger, Cynthia Campbell
CTN-0084Developing a Prescription Opioid Registry across 10 Health SystemsCynthia Campbell
CTN-0077-OTMedical Cannabis Use Among Primary Care Patients: Using Electronic Health Records to Study Large PopulationsGwen Lapham and Katharine Bradley
CTN-0074-A-1Primary Care Opioid Use Disorder Treatment (PROUD) Trial - Economic Analysis StudySean Murphy
CTN-0074Primary Care Opioid Use Disorder Treatment (PROUD) TrialKatharine Bradley
CTN-0072-OTExamine Patient and System-Level Factors Associated with HEDIS AOD-IET Measure Performance across Health Systems

Constance Weisner

 

CTN-0065-OTEvaluation of Drug Screening Implementation in Primary CareKatharine Bradley
CTN-0061-OTKaiser Virtual Data Warehouse - Prescription Opioid UsersCynthia Campbell

 

 

Studies with HSN Investigator Participation

​ CTN Number Protocol Lead Investigators
CTN-0139​​

Collaborative Care for Polysubstance use in Primary Care Settings (Co-Care)

 

HSN Co-Is: Katharine Bradley and Madeline Frost

Jennifer McNeely and Jane Liebschutz
CTN-0131

Office-Based Methadone versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment – A Randomized Pragmatic Hybrid Effectiveness/Implementation Trial

 

HSN Site PI: Ingrid Binswanger

David Fiellin and Paul Joudrey
CTN-0095

Clinic-Randomized Trial of Clinical Decision Support for Opioid Use Disorders in Medical Settings (COMPUTE 2.0)

 

HSN Site PI: Irina Haller

Rebecca Rossom and Gavin Bart

 

​ 

For information on all CTN research studies, click here.
Contact: Monique Buffler 4480 Hacienda Drive, Pleasanton, CA 94588 NIDA Clinical Trials Network   CTN logo